IDEXX Laboratories Inc. (IDXX)

IDEXX Laboratories Inc. (IDXX $568.30)
- $568.30 P/E (TTM): 43.27X Cap: $45.71B
- View IDXX Profile
- View Questions on IDXX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $466.64)
- $466.64 P/E (TTM): 58.59X Cap: $166.80B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $430.14)
- $430.14 P/E (TTM): 28.14X Cap: $109.45B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $197.69)
- $197.69 P/E (TTM): 84.2X Cap: $349.66B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $227.79)
- $227.79 P/E (TTM): 20.63X Cap: $548.33B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $874.00)
- $874.00 P/E (TTM): 38.52X Cap: $825.77B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $110.03)
- $110.03 P/E (TTM): 15.37X Cap: $272.40B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $167.81)
- $167.81 P/E (TTM): 23.15X Cap: $8.15B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $568.30)
- $568.30 P/E (TTM): 43.27X Cap: $45.71B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $63.86)
- $63.86 P/E (TTM): 25.83X Cap: $7.64B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $97.74)
- $97.74 P/E (TTM): 14.77X Cap: $19.04B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $29.44)
- $29.44 P/E (TTM): 16.2X Cap: $3.59B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $26.45)
- $26.45 P/E (TTM): 19.23X Cap: $221.78B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

Adobe Inc. (ADBE $243.20)
- $243.20 P/E (TTM): 14.3X Cap: $98.30B
- View ADBE Profile
- View Questions on ADBE
Accenture plc Class A (Ireland) (ACN $177.75)
- $177.75 P/E (TTM): 14.61X Cap: $117.71B
- View ACN Profile
- View Questions on ACN
Nike Inc. (NKE $45.03)
- $45.03 P/E (TTM): 29.6X Cap: $66.68B
- View NKE Profile
- View Questions on NKE
Thermo Fisher Scientific Inc (TMO $470.22)
- $470.22 P/E (TTM): 26.48X Cap: $174.67B
- View TMO Profile
- View Questions on TMO
TELUS Corporation (T $16.85)
- $16.85 P/E (TTM): 23.39X Cap: $25.79B
- View T Profile
- View Questions on T
IDEXX Laboratories Inc. (IDXX $568.30)
- $568.30 P/E (TTM): 43.27X Cap: $45.71B
- View IDXX Profile
- View Questions on IDXX

Q: Dear 5i,

I have a diverse portfolio with stocks and ETFs. Most of my portfolio is doing well. Want to know your thoughts about a few of my holdings that are not doing so well - Adobe, Nike, Accenture, TMO, IDXX and Telus.

What are your thoughts? Should I replace these with a US ETF or hold on. Thanks for your valuable advice as always.

Read Answer Asked by Alka on November 26, 2025

IDEXX Laboratories Inc. (IDXX $568.30)
- $568.30 P/E (TTM): 43.27X Cap: $45.71B
- View IDXX Profile
- View Questions on IDXX

Q: I bought half a position in IDEXX about a month ago, they recently had about a 25% pop after their results. Would you be comfortable for me adding to my position here?

Read Answer Asked by Andrew on August 11, 2025